Is Drysol (aluminum chloride) effective for treating Athlete's Foot with bacterial overgrowth when used with topical terbinafine (antifungal agent)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drysol (Aluminum Chloride) for Athlete's Foot with Bacterial Overgrowth

Drysol (aluminum chloride) is an effective adjunctive treatment for athlete's foot with bacterial overgrowth when combined with topical terbinafine, as it provides both broad-spectrum antimicrobial activity and chemical drying to suppress the bacterial component that drives symptomatic flare-ups. 1

Rationale for Combination Therapy

The pathophysiology of symptomatic athlete's foot involves a two-stage process: fungal invasion of the horny layer followed by bacterial overgrowth stimulated by moisture accumulation, which causes the wet, macerated presentation. 1

  • Dermatophytes (primarily T. rubrum and T. mentagrophytes) initiate the infection, but large numbers of aerobic diphtheroids and Gram-negative organisms (Pseudomonas, Proteus) are responsible for the symptomatic wet, macerated type of athlete's foot (dermatophytosis complex). 1

  • Suppression of bacteria is essential in treating symptomatic athlete's foot, and aluminum chloride provides a two-pronged attack: broad-spectrum antimicrobial activity combined with chemical drying. 1

Treatment Algorithm

Primary Antifungal Coverage

  • Apply topical terbinafine 1% cream twice daily as the primary antifungal agent, which has superior fungicidal activity against dermatophytes and can achieve 78-89% combined mycologic and clinical cure rates. 2

  • Terbinafine offers the advantage of shorter treatment duration (typically 1 week) compared to other topical agents, though 4 weeks may be needed for chronic cases. 3, 4

Adjunctive Bacterial Suppression

  • Apply aluminum chloride (Drysol) to affected areas to address the bacterial overgrowth component, particularly in wet, macerated interdigital spaces. 1

  • The drying effect is the decisive element in controlling bacterial proliferation that drives symptomatic flare-ups. 1

Alternative Topical Antifungal Options

If terbinafine is not tolerated or available:

  • Ciclopirox olamine 0.77% cream/gel applied twice daily for 4 weeks provides broad-spectrum coverage and achieves approximately 60% cure at end of treatment and 85% two weeks post-treatment. 3, 5

  • Clotrimazole 1% cream twice daily for 4 weeks is less effective but remains a viable alternative. 3, 5

Preventive Measures to Implement Concurrently

  • Thorough drying between toes after showers is critical to prevent moisture accumulation that stimulates bacterial overgrowth. 3, 5

  • Daily sock changes and periodic cleaning of athletic footwear reduce reinfection risk. 3, 5

  • Foot powder application after bathing has been associated with decline in tinea pedis rates from 8.5% to 2.1%, primarily by reducing T. mentagrophytes. 3

  • Wearing nonocclusive leather shoes or sandals enhances evaporation and prevents moisture accumulation. 6

Important Caveats

  • Permanent eradication is unlikely because dermatophyte reservoirs in nails and soles ensure reinfection, making this primarily a seasonal disease in temperate climates requiring periodic treatment of exacerbations. 1

  • Screen for underlying risk factors including obesity and diabetes, which increase susceptibility to tinea pedis and may affect treatment response. 3, 5

  • The dry, scaly type (dermatophytosis simplex) often alternates with the wet, macerated type (dermatophytosis complex), with flare-ups common in summer or with foot occlusion. 1

  • Exposure to air (wearing sandals) enhances water evaporation and prevents bacterial overgrowth more effectively than any topical treatment alone. 1

References

Research

Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine.

Journal of the American Academy of Dermatology, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Topical Treatment for Tinea Pedis in Patients Taking Oral Terbinafine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Athlete's Foot: Clinical Update.

The Physician and sportsmedicine, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.